Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Joji Suzuki, M.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. McGraw Family Innovator Award for Opioid Research (SUZUKI, JOJI) Jan 1, 2020 - Dec 31, 2020
    Brigham Research Institute
    A single-arm, open-label pilot study of cannabidiol on cue-induced cravings for opioid use disorder
    Role: Principal Investigator
  2. R01CE003153 (FISCHER, MICHAEL) Sep 30, 2019 - Sep 29, 2022
    CDC/NCIPC
    Engaging clinicians to improve opioid safety and reduce overdose risk
    Role: Co-Investigator
  3. K23DA042326 (SUZUKI, JOJI) Aug 15, 2017 - Jul 31, 2022
    NIH
    Initiating substance use disorder treatment in hospitalized opioid use disorder patients
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Montalvo C, von Horn A, Lane CE, Weinstein ZM, Sharma M, Suzuki J. Precipitated Withdrawal, Delirium, and Cerebellar Stroke: The Pharmacology of Buprenorphine Induction in Non-pharmaceutical Fentanyl and the Neuropsychiatric Manifestations of Cerebellar Stroke. Harv Rev Psychiatry. 2021 Sep-Oct 01; 29(5):370-377. PMID: 34524778.
    Citations:    Fields:    
  2. Suzuki J, Weiss RD. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2021 04 01; 15(2):91-92. PMID: 32909980.
    Citations:    Fields:    Translation:HumansAnimals
  3. Messinger JC, Suzuki J. Recognizing and Reducing the Impact of Trauma of Hospitalization: Considerations for Persons Who Use Drugs. J Addict Med. 2021 Mar 19. PMID: 33758115.
    Citations:    Fields:    
  4. Blackley SV, MacPhaul E, Martin B, Song W, Suzuki J, Zhou L. Using Natural Language Processing and Machine Learning to Identify Hospitalized Patients with Opioid Use Disorder. AMIA Annu Symp Proc. 2020; 2020:233-242. PMID: 33936395.
    Citations:    Fields:    Translation:Humans
  5. Barnett BS, Morris NP, Suzuki J. Addressing in-hospital illicit substance use. Lancet Psychiatry. 2021 01; 8(1):17-18. PMID: 33341161.
    Citations:    Fields:    Translation:Humans
  6. Ahmed S, Bhivandkar S, Lonergan BB, Suzuki J. Microinduction of Buprenorphine/Naloxone: A Review of the Literature. Am J Addict. 2021 07; 30(4):305-315. PMID: 33378137.
    Citations: 1     Fields:    Translation:Humans
  7. Li L, Martin B, Price C, Suzuki J, Laidlaw TM. Reported drug allergies among patients with opioid use disorder: Role for allergy evaluation and intervention. Ann Allergy Asthma Immunol. 2021 04; 126(4):433-435. PMID: 33387617.
    Citations:    Fields:    Translation:Humans
  8. Suzuki J. Greater Attention Paid to the Patient's Experience Could Improve the Treatment of Individuals With Opioid Use Disorder Hospitalized for Serious Infections. J Addict Med. 2020 12; 14(6):457-458. PMID: 32142057.
    Citations:    Fields:    Translation:Humans
  9. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519. PMID: 32187110.
    Citations:    Fields:    Translation:Humans
  10. Hsu M, Ahern DK, Suzuki J. Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic. JMIR Ment Health. 2020 Oct 26; 7(10):e21814. PMID: 33031044.
    Citations: 3     
  11. Marcovitz DE, Maruti S, Kast KA, Suzuki J. The Use of Therapeutic Metaphor on an Addiction Consult Service. J Acad Consult Liaison Psychiatry. 2021 Jan-Feb; 62(1):102-108. PMID: 33054999.
    Citations:    
  12. Price CN, Solomon DA, Johnson JA, Montgomery MW, Martin B, Suzuki J. Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs. J Infect Dis. 2020 09 02; 222(Suppl 5):S494-S498. PMID: 32877541.
    Citations: 5     Fields:    Translation:Humans
  13. Mitchell LM, Milliken A, Montgomery MW, Singh SK, Suzuki J. The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain. Harv Rev Psychiatry. 2020 Sep/Oct; 28(5):334-340. PMID: 32453063.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Kim JH, Fine DR, Li L, Kimmel SD, Ngo LH, Suzuki J, Price CN, Ronan MV, Herzig SJ. Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: A nationwide observational study. PLoS Med. 2020 08; 17(8):e1003247. PMID: 32764761.
    Citations: 3     Fields:    Translation:Humans
  15. Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286. PMID: 31634202.
    Citations: 3     Fields:    Translation:Humans
  16. Butterfield M, Thorne-Humphrey L, Suzuki J, Herschenhous N. Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients. Am J Addict. 2020 11; 29(6):500-507. PMID: 32490573.
    Citations:    Fields:    Translation:Humans
  17. Hsu M, Farahmand P, Baslet G, Sanchez L, Levy-Carrick NC, Suzuki J. An Impaired Physician with Alcohol Use Disorder and Multiple Medical Comorbidities. Harv Rev Psychiatry. 2020 May/Jun; 28(3):215-223. PMID: 32287085.
    Citations:    Fields:    Translation:Humans
  18. Marcovitz DE, Sidelnik SA, Smith MP, Suzuki J. Motivational Interviewing on an Addiction Consult Service: Pearls, Perils, and Educational Opportunities. Acad Psychiatry. 2020 Jun; 44(3):352-355. PMID: 32100252.
    Citations:    Fields:    Translation:Humans
  19. Ward HB, Mosquera MJ, Suzuki J, Mariano TY. A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder. Neuromodulation. 2020 Apr; 23(3):301-311. PMID: 32059080.
    Citations: 3     Fields:    Translation:Humans
  20. Suzuki J, Robinson D, Mosquera M, Solomon DA, Montgomery MW, Price CD, Johnson JA, Martin B, Liebschutz JW, Schnipper JL, Weiss RD. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Am J Addict. 2020 03; 29(2):155-159. PMID: 31930608.
    Citations: 2     Fields:    Translation:Humans
  21. Tolchin B, Baslet G, Martino S, Suzuki J, Blumenfeld H, Hirsch LJ, Altalib H, Dworetzky BA. Motivational Interviewing Techniques to Improve Psychotherapy Adherence and Outcomes for Patients With Psychogenic Nonepileptic Seizures. J Neuropsychiatry Clin Neurosci. 2020; 32(2):125-131. PMID: 31466516.
    Citations: 3     Fields:    Translation:Humans
  22. Farahmand P, Kim J, Twark C, Suzuki J. Subcutaneous Buprenorphine for a Patient With a History of Misusing an Indwelling Catheter: A Case Report. Psychosomatics. 2020 May - Jun; 61(3):284-287. PMID: 31629483.
    Citations:    Fields:    Translation:Humans
  23. Tolchin B, Baslet G, Suzuki J, Martino S, Blumenfeld H, Hirsch LJ, Altalib H, Dworetzky BA. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia. 2019 05; 60(5):986-995. PMID: 30980679.
    Citations: 5     Fields:    Translation:Humans
  24. Sundaram S, Patil D, Suzuki J. The "White Powder Sign" for Substance Use in Hospitalized Patients. Psychosomatics. 2019 Nov - Dec; 60(6):639-640. PMID: 31153600.
    Citations: 1     Fields:    Translation:Humans
  25. Suzuki J. Assessment and Management of Endocarditis Among People Who Inject Drugs in the General Hospital Setting. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):110-116. PMID: 31975966.
    Citations: 2     
  26. Welsh JW, Suzuki J. Progress and Future: Meeting the Needs of the Nation's Substance Use Crisis. Focus (Am Psychiatr Publ). 2019 Apr; 17(2):87. PMID: 31975962.
    Citations:    
  27. Ward HB, Barnett BS, Suzuki J. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report. Subst Abus. 2019; 40(2):140-145. PMID: 30888254.
    Citations: 1     Fields:    Translation:Humans
  28. Suzuki J, Garayalde S, Dodoo M, Rodriguez C. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids. Subst Abus. 2018; 39(4):518-521. PMID: 29697313.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  29. Weiner SG, Price CN, Atalay AJ, Harry EM, Pabo EA, Patel R, Suzuki J, Anderson S, Ashley SW, Kachalia A. A Health System-Wide Initiative to Decrease Opioid-Related Morbidity and Mortality. Jt Comm J Qual Patient Saf. 2019 01; 45(1):3-13. PMID: 30166254.
    Citations: 8     Fields:    Translation:Humans
  30. Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open Forum Infect Dis. 2018 Sep; 5(9):ofy194. PMID: 30211247.
    Citations: 21     
  31. Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, LeBlanc J, Chang Y, Yu L, Nayak MM, Tulsky JA, Suzuki J, Nabati L, Campbell EG. Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study. J Clin Oncol. 2018 07 01; 36(19):1957-1962. PMID: 29746226.
    Citations: 25     Fields:    Translation:Humans
  32. Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29. PMID: 29141667.
    Citations: 3     Fields:    Translation:Humans
  33. Suzuki J, Zinser J, Issa M, Rodriguez C. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment. Subst Abus. 2017 Oct-Dec; 38(4):504-507. PMID: 28723256.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  34. Twark C, Suzuki J. Fenethylline-Induced Psychosis, Fenethylline-Themed Paranoid Delusions, or Both? Psychosomatics. 2017 Sep - Oct; 58(5):561-564. PMID: 28577859.
    Citations: 1     Fields:    Translation:Humans
  35. Braun IM, Meyer FL, Gagne JJ, Nabati L, Yuppa DP, Carmona MA, Burstein HJ, Suzuki J, Nayak MM, Martins Y. Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study. Psychooncology. 2017 08; 26(8):1087-1092. PMID: 28040884.
    Citations: 5     Fields:    Translation:Humans
  36. Suzuki J, Valenti ES. Intentional Intra-arterial Injection of Heroin: A Case Report. J Addict Med. 2017 Jan/Feb; 11(1):77-79. PMID: 28027191.
    Citations: 1     Fields:    Translation:Humans
  37. Suzuki J, El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017 Feb 01; 171:107-116. PMID: 28068563.
    Citations: 73     Fields:    Translation:Humans
  38. Welsh JW, Rodriguez C, Suzuki J. Bilateral Upper Extremity Cellulitis From Injecting Crack Cocaine Dissolved in Lemon Juice: A Case Report. Prim Care Companion CNS Disord. 2016 Oct 13; 18(5). PMID: 27835731.
    Citations: 1     Fields:    Translation:HumansAnimals
  39. Hardaway R, Schweitzer J, Suzuki J. Hallucinogen Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):489-96. PMID: 27338969.
    Citations: 2     Fields:    Translation:Humans
  40. Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016 Apr; 25(3):191-4. PMID: 26991660.
    Citations: 16     Fields:    Translation:Humans
  41. Dwyer-Clonts M, Frates E, Suzuki J. Managing Problem Drinking: Screening Tools and Brief Interventions for Primary Care Physicians. Am J Lifestyle Med. 2017 Nov-Dec; 11(6):424-429. PMID: 30202365.
    Citations:    
  42. Suzuki J, Dodds T. Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment. Subst Abus. 2016; 37(1):31-4. PMID: 26682722.
    Citations: 2     Fields:    Translation:Humans
  43. Rodriguez CP, Vaidya A, Tishler LW, Suzuki J. INTERACTIVE MEDICAL CASE. A Painful Subject. N Engl J Med. 2015 Dec 24; 373(26):e32. PMID: 26699187.
    Citations:    Fields:    Translation:Humans
  44. Mittal L, Suzuki J. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Subst Abus. 2017 Jul-Sep; 38(3):261-264. PMID: 26672650.
    Citations: 1     Fields:    Translation:Humans
  45. Minen MT, Lindberg K, Wells RE, Suzuki J, Grudzen C, Balcer L, Loder E. Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center. Headache. 2015 Oct; 55(9):1183-91. PMID: 26316376.
    Citations: 3     Fields:    Translation:Humans
  46. Shu J, Huang H, Suzuki J. The Early-Career Consultation Psychiatrist: Leading the Integration of Substance Use Treatment Into the Primary Care Setting. Psychosomatics. 2015 Nov-Dec; 56(6):706-7. PMID: 26674483.
    Citations:    Fields:    Translation:Humans
  47. Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry. 2016 Jun; 40(3):498-502. PMID: 26017618.
    Citations: 3     Fields:    Translation:Humans
  48. Sivashanker K, Mufson M, Mittal L, Ross E, Suzuki J. Challenges in managing acute on chronic pain in a pregnant woman at high risk for opioid use disorder in the general hospital setting. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):157-66. PMID: 25747928.
    Citations: 1     Fields:    Translation:Humans
  49. Suzuki J, Zinser J, Klaiber B, Hannon M, Grassi H, Spinosa M, Ramirez A, Issa M, Chin Feman SP. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study. Subst Abus. 2015; 36(2):166-9. PMID: 25738320.
    Citations: 7     Fields:    Translation:Humans
  50. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06. PMID: 25376754.
    Citations:    
  51. Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015 Mar-Apr; 56(2):129-39. PMID: 25659919.
    Citations: 17     Fields:    Translation:Humans
  52. Suzuki J, Poklis JL, Poklis A. "My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):379-82. PMID: 25364988.
    Citations: 8     Fields:    Translation:Humans
  53. Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014 Nov-Dec; 23(6):618-22. PMID: 25065457.
    Citations: 9     Fields:    Translation:Humans
  54. Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68. PMID: 24944066.
    Citations: 8     Fields:    Translation:Humans
  55. Huang H, Chan YF, Bauer AM, Suzuki J, Katon W, Russo J, Hogan D, Unützer J. Specialty behavioral health service use among chronically ill medicare advantage patients with substance use problems. Psychosomatics. 2013 Nov-Dec; 54(6):546-51. PMID: 23932530.
    Citations:    Fields:    Translation:Humans
  56. Isomura T, Suzuki J, Murai T. Paradise Lost: The relationships between neurological and psychological changes in nicotine-dependent patients. Addict Res Theory. 2014 Apr; 22(2):158-165. PMID: 24719610.
    Citations: 2     
  57. Suzuki J, Meyer F, Wasan AD. Characteristics of medical inpatients with acute pain and suspected non-medical use of opioids. Am J Addict. 2013 Sep-Oct; 22(5):515-20. PMID: 23952900.
    Citations: 3     Fields:    Translation:Humans
  58. Suzuki J, Mittal L, Woo SB. Sublingual buprenorphine and dental problems: a case series. Prim Care Companion CNS Disord. 2013; 15(5). PMID: 24511440.
    Citations:    Fields:    
  59. Suzuki J, Park EM. Buprenorphine/naloxone and dental caries: a case report. Am J Addict. 2012 Sep-Oct; 21(5):494-5. PMID: 22882403.
    Citations: 1     Fields:    Translation:Humans
  60. Park EM, Meltzer-Brody S, Suzuki J. Evaluation and management of opioid dependence in pregnancy. Psychosomatics. 2012 Sep-Oct; 53(5):424-32. PMID: 22902085.
    Citations: 5     Fields:    Translation:Humans
  61. Freedman JL, Crow FF, Gutheil TG, Sanchez LT, Suzuki J. Treating a physician patient with psychosis. Asian J Psychiatr. 2012 Jun; 5(2):193-8. PMID: 22813669.
    Citations: 2     Fields:    Translation:Humans
  62. Park EM, Suzuki J. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report. Am J Addict. 2012 May-Jun; 21(3):283-4. PMID: 22494234.
    Citations:    Fields:    Translation:Humans
  63. Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012 Feb; 22(2):201-7. PMID: 21188544.
    Citations: 40     Fields:    Translation:Humans
  64. Suzuki J, Chang G. Consultation to the medically ill: a survey of addiction psychiatry fellowship programs. Am J Addict. 2011 Sep-Oct; 20(5):476-7. PMID: 21838848.
    Citations:    Fields:    
  65. Suzuki J, Gitlin DF, Chang G. Survey of psychosomatic medicine fellowships: training in substance use disorders. Psychosomatics. 2011 May-Jun; 52(3):296-7. PMID: 21565606.
    Citations:    Fields:    Translation:Humans
  66. Suzuki J, Tyson JW. Misconceptions about the safety of ingesting methanol-based solid fuels: a case report. Prim Care Companion CNS Disord. 2011; 13(2). PMID: 21977352.
    Citations:    Fields:    
  67. Halpern JH, Suzuki J, Huertas PE, Passie T. Addiction Medicine: Science and Practice. Edited by Johnson BA. Hallucinogens. 2010; p1083-98.
  68. Renner JA & Suzuki J. Addiction Medicine: Science and Practice. Edited by Johnson BA. Opiates and prescription drugs. 2010; p463-94.
  69. Suzuki J. Handbook of office-based buprenorphine treatment of opioid dependence. Edited by Renner JA, Levounis P. Logistics of office-based opioid treatment with buprenorphine. 2010; pp 253-274.
  70. Halpern JH, Suzuki J, Huertas PE, Passie T. Encyclopedia of Psychopharmacology. Edited by Stolerman IP. Hallucinogen abuse and dependence. 2010; pp569-572.
  71. Suzuki J, Halpern JH, Passie T, Huertas PE. Pharmacology and Treatment of Substance Abuse: Evidence- and Outcome-Based Perspectives. Edited by Cohen LM, Collins FL, Young AM, McChargue DE, Leffingwell TR, Cook KL. Hallucinogens. 2009; pp319-418.
  72. Van Der Kolk BA, Burbridge JA, Suzuki J. The psychobiology of traumatic memory. Clinical implications of neuroimaging studies. Ann N Y Acad Sci. 1997 Jun 21; 821:99-113. PMID: 9238197.
    Citations: 10     Fields:    Translation:Humans
  73. van der Kolk BA, Burbridge JA, Suzuki J. Acta Neuropsychiatrica. Current status on the psychobiology of posttraumatic stress disorder. 1995; 7(S):34-37.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Suzuki's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (209)
Explore
_
Co-Authors (49)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.